Sanofi Pasteur Supplies Bird Flu Vaccine to Italy
Posted on: Wednesday, 1 March 2006, 09:01 CST
Sanofi Pasteur, the vaccines business of the Sanofi-Aventis Group, has supplied a stock of pre-pandemic vaccine against the H5N1 avian influenza virus strain to the Italian Ministry of Health.
Under the agreement Sanofi Pasteur may also provide pandemic vaccine to the Italian Ministry in the event of a pandemic being declared, once the actual virus strain responsible is identified.
If formulated at a concentration of 15 micrograms of H5N1 antigen per dose, the stock delivered is expected to allow the preparation of 185,000 doses of vaccine.
The contract with the Italian government will be carried out in collaboration with Sanofi Pasteur MSD, Sanofi Pasteur's joint venture with Merck & Co for the development and distribution of vaccines in Europe.
Recently, Sanofi Pasteur announced that preliminary results of clinical trials fielded in France with the vaccine demonstrated a good immune response in a significant number of volunteers.
The avian H5N1 strain is one of the candidates that could lead to a global influenza pandemic, although currently there is no transmission to and among humans.
Source: Datamonitor
Related Articles
- Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for Its Influenza Vaccine Global Stockpile
- U.S. Government Accepts $192 Million of Sanofi Pasteur H5N1 Bulk Vaccine Antigen for Pandemic Stockpile
- Receptor Logic Teams With Sanofi Pasteur to Develop T Cell Receptor Mimics (TCRm(TM)) for Vaccine Research
- Maxygen Licenses Dengue Vaccine Technology to Sanofi Pasteur
- Sanofi Pasteur Signs Contract With U.S. Government for Stockpile of New Type of H5N1 Pre-Pandemic Vaccine
- Sanofi Pasteur Broadens Pandemic Preparedness With First Clinical Trial Of Novel PER.C6(R)-Based H7N1 Vaccine
- Sanofi Pasteur Broadens Pandemic Preparedness With First Clinical Trial of Novel Cell-Based H7N1 Vaccine
- Adjuvanted Formulation of Sanofi Pasteur H5N1 Pandemic Influenza Vaccine Candidate Demonstrates Significant Immune Response
- Sanofi Pasteur Supplies Prototype Vaccinefor Italian Government Pandemic Initiatives
- Sanofi Pasteur to Produce 100 M US Dollars of Vaccine Against H5N1 Influenza Virus for U.S. Government
 |
 |
User Comments (0)
RSS Feeds